Isoprenaline Hydrochloride
盐酸异丙肾上腺素
Report date: 2023/03/16 20:00:26
Base Information
Drug NameIsoprenaline Hydrochloride
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[10]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesAlfresa PharmaThe University Of ArizonaSandoz Canada Inc +[7]
Inactive CompaniesSanofi
Active Indications +[10]
Inactive IndicationsN/A